- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06848686
Prevention Ambassadors: Intervention to Promote HIV Service Engagement in the Networks of SSP Clients
Prevention Ambassadors: an HIV Self-testing Intervention to Promote HIV Service Engagement in the Networks of SSP Clients
HIV testing and service uptake are infrequent among people who use drugs (PWUD) in the United States. In partnership with a community-based syringe service program (SSP), this project will develop the SSP-based "Prevention Ambassadors" (PA) intervention to promote HIV testing and service uptake among PWUD via the secondary distribution (i.e., peer delivery) of HIV self-testing (HIVST) kits with local HIV service information and referrals to HIV service navigation in the social networks of SSP clients (i.e., PWUD). The PA intervention will then be piloted to assess its preliminary effects, acceptability, and feasibility among PWUD in the Ending the HIV Epidemic priority jurisdiction of Riverside County, California.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
San Diego, California, United States, 92182
- San Diego State University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Index Participant Inclusion Criteria:
- Being greater than or equal to 18 years old
- Reporting drug use (past month)
- Having other people who use drugs (PWUD) in one's social network
- Being willing to talk about HIV testing and services with at least 2 PWUD in their networks and attempt to refer them to the study
- Speaking English fluently
Peer-Recruit Participant Inclusion Criteria:
- Being greater than or equal to 18 years old
- Reporting drug use (past 3 months)
- Being recruited by an index participant (evidenced by presenting the coupon used to recruit them)
- Speaking English fluently
Exclusion Criteria:
- Persons who participated in formative study activities related to the development of the PA intervention will not be eligible to participate.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Prevention Ambassadors
|
Delivery of prevention supplies and information on local services plus training to build the capacity of PWUD to distribute HIV self-testing (HIVST) kits with information and referrals to other PWUD in their social networks to promote HIV testing and HIV service engagement among PWUD. |
|
Other: SSP Standard of Care
|
Delivery of prevention supplies and information on local services. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
HIV testing (past 3 months)
Time Frame: 3-month follow-up
|
Self-reported via survey and abstracted from medical record |
3-month follow-up
|
|
Linkage to PrEP/HIV care (past 3 months)
Time Frame: 3-month follow-up
|
Self-reported via survey and abstracted from medical record |
3-month follow-up
|
|
PrEP/ART uptake (past 3 months)
Time Frame: 3-month follow-up
|
Self-reported via survey and abstracted from medical record |
3-month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PA Acceptability (Peer-Recruit Participants)
Time Frame: Baseline
|
Self-reported via survey |
Baseline
|
|
PA Acceptability (Index Participants)
Time Frame: 3-month follow-up
|
Self-reported via survey |
3-month follow-up
|
|
PA Feasibility (Peer-Recruit Participants)
Time Frame: Baseline
|
Self-reported via survey |
Baseline
|
|
PA Feasibility (Index Participants)
Time Frame: 3-month follow-up
|
Self-reported via survey |
3-month follow-up
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Heather A Pines, San Diego State University
- Principal Investigator: Angela R Bazzi, University of California, San Diego
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- HS-2023-0051
- R34DA058389 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
De-identified data will be made available upon review of written requests from researchers.
IPD Sharing Time Frame
Approximately 6 months after the publication of the study's primary findings.
IPD Sharing Access Criteria
Requests from researchers for de-identified data will be reviewed by the research team (Multiple Principal Investigators and Co-Investigators).
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.